Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients
Acta Ophthalmologica · 2025
DOI: 10.1111/aos.70047 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Alexander von Spreckelsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Intraocular Pressure, Patient Preference, Antihypertensive Agents, Ocular Hypertension. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Dansk Glaukom Forening (The Danish Glaucoma Association), Frimodt-Heineke Fonden, Dagmar Marshalls Fond.
Abstract (Originalsprache)
Purpose
Assessment of patient preferences for local adverse effects (AEs) of intraocular pressure (IOP)‐lowering eye drops.
Methods
A total of 10 000 eye drop‐treated patients aged 40–75 years were sampled from the Danish national registries. A discrete choice experiment (DCE) was distributed to each patient to elicit preferences for distinct levels of five representative local AE attributes of IOP‐lowering drops: acute discomfort, persistent discomfort, blurred vision, non‐persistent cosmetic changes, and persistent cosmetic changes. Preference weights were computed using conditional logistic regression and normalised using profile‐based normalisation. The mildest severity levels were used as a reference. Heterogeneity analyses were conducted across patient covariates to examine variation in preference patterns.
Results
A total of 2445 patients (24% response rate; 55% male; median age: 67 years) completed the DCE, with 2096 providing additional covariate data. 95% reported a diagnosis of glaucoma or ocular hypertension. More females than males reported currently experiencing AEs (48% vs. 35%). 25% had previously discontinued treatment with IOP‐lowering eye drops due to AEs. The DCE revealed significant differences in the patients' preferences for avoiding AEs. Severe blurred vision, persistent cosmetic changes, and persistent discomfort exhibited the highest levels of disutility. Moderate acute discomfort and non‐persistent cosmetic changes were least important. The patients' preferences varied notably by age and gender.
Conclusion
This study provides novel insight into patients' preferences for AEs of IOP‐lowering eye drops by identifying the characteristics that most strongly influence treatment choices. These insights support future clinical studies and shared decision‐making, facilitating personalised care that can improve adherence, quality of life, and long‐term patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Ophthalmology, Copenhagen University Hospital, Glostrup, Denmark.
- Department of Public Health, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
- Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, Nordsjaellands Hospital (North Zealand Hospital), Hilleroed, Denmark.
- The Prehospital Center, Naestved, Denmark.
ORCID-Profile: Alexander von Spreckelsen, Trine Kjær, Marcel Reimann, Christian Torp-Pedersen, Mikkel Porsborg Andersen, Gianni Virgili, Augusto Azuara-Blanco, Dorte Gyrd-Hansen, Miriam Kolko
Förderung
- Dansk Glaukom Forening (The Danish Glaucoma Association)
- Frimodt-Heineke Fonden
- Dagmar Marshalls Fond
Zitieren
APA
von Spreckelsen, A., Kjær, T., Reimann, M., Torp-Pedersen, C., Porsborg Andersen, M., Virgili, G., Azuara-Blanco, A., Gyrd-Hansen, D., & Kolko, M. (2025). Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients. Acta Ophthalmologica. https://doi.org/10.1111/aos.70047
Vancouver
von Spreckelsen A, Kjær T, Reimann M, Torp-Pedersen C, Porsborg Andersen M, Virgili G, et al. Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients. Acta Ophthalmologica. 2025. doi:10.1111/aos.70047
BibTeX
@article{vonSpreckelsen2025,
author = {von Spreckelsen, Alexander and Kjær, Trine and Reimann, Marcel and Torp-Pedersen, Christian and Porsborg Andersen, Mikkel and Virgili, Gianni and Azuara-Blanco, Augusto and Gyrd-Hansen, Dorte and Kolko, Miriam},
title = {Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients},
journal = {Acta Ophthalmologica},
year = {2025},
doi = {10.1111/aos.70047}
}
EUVIMED